CLPS (NASDAQ:CLPS) Cut to Hold at ValuEngine

Share on StockTwits

CLPS (NASDAQ:CLPS) was downgraded by equities research analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued on Friday, ValuEngine reports.

CLPS opened at $5.57 on Friday. CLPS has a twelve month low of $2.12 and a twelve month high of $17.99.

An institutional investor recently raised its position in CLPS stock. Morgan Stanley increased its stake in CLPS Inc (NASDAQ:CLPS) by 87.7% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,468 shares of the company’s stock after purchasing an additional 6,294 shares during the period. Morgan Stanley owned 0.10% of CLPS worth $139,000 as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 0.63% of the company’s stock.

CLPS Company Profile

CLPS Incorporation provides information technology and consulting services to banking, insurance, and financial sectors in the People's Republic of China and internationally. It offers IT consulting services in credit card business areas, such as credit card application, account setup, authorization and activation, settlement, collection, promotion, point system, anti-fraud, statement, reporting, and risk management.

See Also: How mutual funds make money

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for CLPS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CLPS and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

AngioDynamics  vs. Westaim  Financial Analysis
AngioDynamics vs. Westaim Financial Analysis
Translate Bio  versus Pharmacyte Biotech  Financial Survey
Translate Bio versus Pharmacyte Biotech Financial Survey
Oxford Industries  & Kontoor Brands  Critical Contrast
Oxford Industries & Kontoor Brands Critical Contrast
Golden Bull  versus Senmiao Technology  Head to Head Comparison
Golden Bull versus Senmiao Technology Head to Head Comparison
Endologix  and Merit Medical Systems  Head-To-Head Review
Endologix and Merit Medical Systems Head-To-Head Review
Wildhorse Resource Development  & Matador Resources  Head to Head Contrast
Wildhorse Resource Development & Matador Resources Head to Head Contrast


© 2006-2019 Ticker Report